Loading...
Neuraminidase inhibitors--the story behind the Cochrane review
Authors
Doshi, Peter
Doshi, Peter
Advisor
Date
2009-12-08
Embargo until
Language
Book title
Publisher
BMJ Publishing Group
Peer Reviewed
Type
Article
Research Area
Jurisdiction
Collections
Other Titles
Abstract
Data Availibility
Data / Code Location
Table of Contents
Description
Although billions have been spent on oseltamivir in the face of pandemic influenza, the team updating the Cochrane review of neuraminidase inhibitors in healthy adults found that the public evidence base for this global public health drug was fragmented and inconsistent. Peter Doshi tells the story
Citations
Altmetric:
Series/Report No.
Sponsors
Rights/Terms
Citation
Doshi P. (2009). Neuraminidase inhibitors--the story behind the Cochrane review. BMJ 2009;339:b5164. DOI: https://doi.org/10.1136/bmj.b5164